Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to equity ratio high or low?
The debt to equity ratio of -1.71 is 982% below its 5-year average of 0.19, around the middle of its 5-year range (-12.67–7.79).
As of the fiscal period ended Tuesday, March 31, 2026. 60.29% above its 12-month average of -4.31.
Reported quarterly debt to equity ratio; no daily interpolation. Q1 FY2026 (2026-03-31): -1.71.
DEBT TO EQUITY RATIO
-1.71
DEBT TO EQUITY RATIO AVG TTM
-4.31
DEBT TO EQUITY RATIO AVG 3Y
0.27
DEBT TO EQUITY RATIO AVG 5Y
0.19
DEBT TO EQUITY RATIO AVG 10Y
N/A
DEBT TO EQUITY RATIO AVG 15Y
N/A
DEBT TO EQUITY RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+60.29%
CURRENT VS 3Y AVG
-740.50%
CURRENT VS 5Y AVG
-982.41%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.14
median of 474 covered companies
CURRENT VS SECTOR MEDIAN
-1321.58%
vs the sector median at left
Celularity Inc.
Market Cap
$50.37M
Debt to Equity Ratio
-1.71
TTM Avg
-4.31
3Y Avg
0.27
5Y Avg
0.19
Market Cap
$51.78M
Debt to Equity Ratio
0.25
TTM Avg
0.00
3Y Avg
0.00
5Y Avg
0.00
Market Cap
$52.80M
Debt to Equity Ratio
0.00
TTM Avg
0.12
3Y Avg
0.06
5Y Avg
0.04
| NAME | MARKET CAP | DEBT TO EQUITY RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Celularity Inc. (CELU) | $50.37M | -1.71 | -4.31 | 0.27 | 0.19 |
| Apollomics, Inc. (APLM)vs › | $50.51M | N/A | 0.15 | 0.15 | 0.15 |
| biote Corp. (BTMD)vs › | $50.67M | N/A | 9.05 | 9.05 | 9.05 |
| Clene Inc. (CLNN)vs › | $49.84M | N/A | 6.12 | 6.71 | 4.67 |
| eXoZymes, Inc. (EXOZ)vs › | $51.23M | 0.30 | 0.25 | 0.31 | 0.39 |
| INmune Bio, Inc. (INMB)vs › | $51.71M | 0.07 | 0.03 | 0.14 | 0.13 |
| Envoy Medical, Inc. (COCH)vs › | $51.78M | 0.25 | 0.00 | 0.00 | 0.00 |
| Dogwood Therapeutics, Inc. (DWTX)vs › | $52.80M | 0.00 | 0.12 | 0.06 | 0.04 |
| ImageneBio Inc (IMA)vs › | $53.01M | 0.01 | 0.07 | 0.06 | 0.05 |
| Lite Strategy, Inc. (LITS)vs › | $47.30M | 0.00 | 0.00 | 0.13 | 0.14 |
Debt/Equity
-1.71
Current Ratio
0.09
Debt to Equity measures financial leverage by comparing total debt to shareholders' equity.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO EQUITY RATIO |
|---|---|
| 2026-03-31 | -1.71 |
| 2025-12-31 | -1.07 |
| 2025-09-30 | -3.32 |
| 2025-06-30 | -2.75 |
| 2025-03-31 | -12.67 |
| 2024-12-31 | 7.79 |
| 2024-09-30 | 4.00 |
| 2024-06-30 | 1.14 |
| 2024-03-31 | 2.11 |
| 2023-12-31 | 1.60 |
| 2023-09-30 | 2.02 |
| 2023-06-30 | 0.52 |
| 2023-03-31 | 0.41 |
| 2022-12-31 | 0.33 |
| 2022-09-30 | 0.41 |
| 2022-06-30 | 0.19 |
| 2022-03-31 | 0.34 |
| 2021-12-31 | 0.31 |
| 2021-09-30 | 0.32 |
| 2021-06-30 | -0.37 |
| 2021-03-31 | -0.50 |
| 2020-12-31 | 1.64 |
| 2020-09-30 | 2.22 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
| 2019-12-31 | 0.20 |
| 2019-09-30 | 0.00 |
| 2019-06-30 | 0.00 |
| 2019-03-31 | 6.31 |
